Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 543-548 , July 2008

Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice

  • Philipp T. Meyer

      Affiliations

    • Department of Neurology, University Hospital Aachen, 52074 Aachen, Germany
    • Department of Nuclear Medicine, University Hospital Aachen, 52074 Aachen, Germany
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, University Hospital Aachen, 52074 Aachen, Germany. Tel.: +49 0 241 8088743; fax: +49 0 241 8082520.
    • ,
  • Dagmar Salber

      Affiliations

    • C. & O. Vogt Institute of Brain Research, University Hospital Duesseldorf, 40225 Duesseldorf, Germany
    • ,
  • Johannes Schiefer

      Affiliations

    • Department of Neurology, University Hospital Aachen, 52074 Aachen, Germany
    • ,
  • Markus Cremer

      Affiliations

    • Institute of Neurosciences and Biophysics - Medicine, Research Center Juelich, 52425 Juelich, Germany
    • ,
  • Wolfgang M. Schaefer

      Affiliations

    • Department of Nuclear Medicine, University Hospital Aachen, 52074 Aachen, Germany
    • ,
  • Christoph M. Kosinski

      Affiliations

    • Department of Neurology, University Hospital Aachen, 52074 Aachen, Germany
    • ,
  • Karl-Josef Langen

      Affiliations

    • Institute of Neurosciences and Biophysics - Medicine, Research Center Juelich, 52425 Juelich, Germany

Received 28 February 2008 ,Revised 10 March 2008 ,Accepted 17 March 2008.

References 

  1. Acton PD, Choi SR, Plossl K, Kung HF. Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography. Eur J Nucl Med Mol Imaging. 2002;29:691–698
  2. Meyer PT, Circiumaru V, Cardi CA, Thomas DH, Bal H, Acton PD. Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function. Eur J Nucl Med Mol Imaging. 2006;33:948–954
  3. Saji H, Iida Y, Kawashima H, Ogawa M, Kitamura Y, Mukai T, et al. In vivo imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography. Anal Sci. 2003;19:67–71
  4. Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstatter M, Stefanova N, et al. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats. NeuroImage. 2005;24:822–831
  5. Vastenhouw B, Beekman F. Submillimeter total-body murine imaging with U-SPECT-I. J Nucl Med. 2007;48(3):487–493
  6. Kung HF, Guo YZ, Billings J, Xu X, Mach RH, Blau M, et al. Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. Int J Radiat Appl Instrum B. 1988;15:195–201
  7. Meyer PT, Salber D, Schiefer J, Cremer M, Schaefer WM, Kosinski CM, et al. Cerebral kinetics of the dopamine D2 receptor ligand [123I]IBZM in mice. Nucl Med Biol. 2008;35:467–473
  8. Pissarek MB, Oros-Peusquens AM, Schramm NU. Challenge by the murine brain: multi-pinhole SPECT of (123)I-labelled pharmaceuticals. J Neurosci Methods. 2008;168:282–292
  9. Nanni C, Pettinato C, Ambrosini V, Spinelli A, Trespidi S, Rubello D, et al. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. Nucl Med Commun. 2007;28:547–553
  10. Marsteller DA, Barbarich-Marsteller NC, Fowler JS, Schiffer WK, Alexoff DL, Rubins DJ, et al. Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-d-glucose cerebral uptake in rodents through time. Nucl Med Biol. 2006;33:71–79
  11. Schiffer WK, Mirrione MM, Dewey SL. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. J Nucl Med. 2007;48:277–287
  12. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med. 2006;47:999–1006
  13. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493–506
  14. Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci U S A. 1998;95:6480–6485
  15. Langen KJ, Jarosch M, Mühlensiepen H, Hamacher K, Bröer S, Jansen P, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol. 2003;30:501–508
  16. Camps M, Kelly PH, Palacios JM. Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect. 1990;80:105–127
  17. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533–1539
  18. Arioli V, Rossi E. Errors related to different techniques of intraperitoneal injection in mice. Appl Microbiol. 1970;19:704–705
  19. Meibach RC, Glick SD, Ross DA, Cox RD, Maayani S. Intraperitoneal administration and other modifications of the 2-deoxy-d-glucose technique. Brain Res. 1980;195:167–176
  20. Kelly PA, McCulloch J. A potential error in modifications of the [14C]2-deoxyglucose technique. Brain Res. 1983;260:172–177
  21. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med. 1995;36:1182–1190
  22. Verhoeff NP, Bobeldijk M, Feenstra MG, Boer GJ, Maas MA, Erdtsieck-Ernste E, et al. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain. Int J Radiat Appl Instrum B. 1991;18:837–846
  23. Acton PD, Hou C, Kung MP, Plossl K, Keeney CL, Kung HF. Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF. Eur J Nucl Med Mol Imaging. 2002;29:1507–1515
  24. Brucke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, et al. In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT. Life Sci. 1988;42:2097–2104
  25. Flessner MF, Lofthouse J, Williams A. Increasing peritoneal contact area during dialysis improves mass transfer. J Am Soc Nephrol. 2001;12:2139–2145
  26. Levitt MD, Kneip JM, Overdahl MC. Influence of shaking on peritoneal transfer in rats. Kidney Int. 1989;35:1145–1150

PII: S0969-8051(08)00076-0

doi: 10.1016/j.nucmedbio.2008.03.006

Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 543-548 , July 2008

Article Tools

* Image Usage & Resolution